Home
/

What is an MPV Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

MPV measures the average size of circulating platelets—the tiny cell fragments that trigger clotting—with size tracking platelet age and reactivity. Most labs report a reference range around 7–11 fL; larger platelets are younger and more reactive, while smaller ones are older. A high MPV paired with elevated platelet count is associated with clotting risk relevant to cardiovascular health, whereas extremes with low counts may help contextualize bleeding tendencies.

Read more →
Table of contents

MPV: The Average Size of Your Platelets

Mean Platelet Volume (MPV) is the average size of your platelets—the tiny, anucleate cell fragments that help your blood clot. Platelets are shed from large bone-marrow cells called megakaryocytes and circulate for several days before being cleared. MPV summarizes how big these circulating platelets are at a given time (platelet volume), offering a snapshot of their typical size and, indirectly, their stage of life and production pattern (thrombopoiesis).

Why size matters: platelet size tracks with their contents and behavior. Larger platelets tend to carry more granules and enzymes and are often more ready to act at an injury site, while smaller platelets are generally further along in their lifespan. By condensing this biology into a single number, MPV reflects the balance between platelet production, maturation, and use (turnover), and gives context for how prepared the platelet pool is to support normal clot formation (hemostasis) and to respond to inflammatory signals. In short, MPV is a compact window into platelet biology (platelet reactivity and activation) rather than a measure of clotting by itself.

Why Platelet Size Reveals Marrow and Vascular Signals

Mean Platelet Volume (MPV) measures the average size of your platelets—the cells that patch leaks and build clots. Size reflects how the bone marrow is producing and releasing platelets, how quickly they're being used up in the bloodstream, and how "reactive" they are. Because clotting and inflammation touch every organ, MPV offers a window into vascular health, immune activity, and marrow function.

Size tracks platelet age and activity: larger platelets are younger and generally more reactive. MPV helps interpret how the bone marrow is producing platelets and how quickly they are being used, linking to clotting readiness, vascular inflammation, and overall cardiometabolic and immune tone.

Reading MPV Across the Range

Most labs report a reference range roughly around 7–11, with values near the middle typically seen in healthy, steady platelet turnover. Small shifts within range are common; persistent values at the extremes carry more meaning. Being in range suggests balanced platelet production and turnover, with steady hemostasis and controlled inflammatory signaling. Most healthy individuals sit near the middle of the laboratory reference range, indicating stable marrow output and low-grade platelet activation.

When MPV is on the lower side, platelets tend to be smaller and older, pointing to slower marrow production or long platelet lifespan. If the platelet count is also low, bleeding signs may show up—easy bruising, nosebleeds, gum bleeding, or heavier menstrual flow. In children, recurrent nosebleeds or prolonged bleeding after minor cuts may be noticed. During pregnancy, low MPV alone is usually not a major signal unless paired with a low count.

Low values usually reflect slower platelet production or a circulation dominated by older, smaller platelets (reduced thrombopoiesis). System-level effects tend toward lower platelet reactivity and, when paired with a low platelet count, a greater bleeding tendency. Very low MPV with low count suggests inherited microplatelet disorders, though these are uncommon. In isolation with a normal count, low MPV is often less clinically significant.

Higher MPV means larger, younger, more reactive platelets, often seen when the body is consuming platelets (for example, immune destruction) or during recovery after marrow stress. With a low count, bruising and mucosal bleeding can still occur; with a normal or high count, larger platelets can tilt toward clotting, relevant to heart, brain, and placental circulation, and has been linked to cardiovascular risk.

High values usually reflect accelerated turnover with release of larger, younger platelets due to peripheral consumption or destruction (inflammation, bleeding, immune-mediated loss) or recovery after cytopenia; MPV can also be higher after splenectomy. System-level effects include higher platelet reactivity and, in some studies, association with cardiometabolic and vascular risk. When MPV is high and the platelet count is low, consumptive or destructive processes are more likely.

Sample Handling and Conditions That Skew MPV

MPV is analyzer- and time-dependent; EDTA samples swell over hours, raising MPV, so timing matters. Interpret MPV alongside the platelet count and smear. Values may trend slightly higher in late pregnancy and with acute illness. Platelet clumping or delayed processing can distort results.

What MPV Adds to a CBC Reading

MPV integrates bone marrow activity, inflammation, and vascular reactivity. Interpreted alongside the platelet count and clinical context, it helps gauge bleeding versus clotting tendencies and connects to long-term heart–brain health.

FAQs

Mean Platelet Volume (MPV) testing reports the average size of your platelets, expressed in femtoliters, as part of a Complete Blood Count. It reflects platelet production and turnover and adds context to clotting function.

Testing MPV helps you understand platelet reactivity, bleeding and clotting balance, recovery after illness, and how inflammation or metabolic factors may influence cardiovascular risk.

Frequency depends on your goals. For trend tracking, use a consistent schedule and method; during recovery or flare periods, more frequent checks can highlight early shifts.

Smoking, glucose control, sleep, activity, infections, inflammation, and bone marrow stress can influence MPV. Collection timing and sample handling also affect results.

MPV is part of a standard CBC and typically requires no special preparation. Consistent timing and prompt sample processing improve reliability.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Korniluk, A., Koper-Lenkiewicz, O. M., Kamińska, J., Kemona, H., & Dymicka-Piekarska, V. (2019). Mean platelet volume (MPV): New perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators of Inflammation, 2019, 9213074. https://doi.org/10.1155/2019/9213074
  2. Gasparyan, A. Y., Ayvazyan, L., Mikhailidis, D. P., & Kitas, G. D. (2011). Mean platelet volume: A link between thrombosis and inflammation? Current Pharmaceutical Design, 17(1), 47-58. https://doi.org/10.2174/138161211795049804
  3. Ali, N. T. (2025). Mean corpuscular volume (MCV) and mean platelet volume (MPV) as early diagnostic markers for preeclampsia, gestational diabetes, and anemia: A systematic review of clinical evidence and mechanisms. BMC Pregnancy and Childbirth, 25(1), 722. https://doi.org/10.1186/s12884-025-07802-x
  4. Mandel, J., Casari, M., Stepanyan, M., Martyanov, A., & Deppermann, C. (2022). Beyond hemostasis: Platelet innate immune interactions and thromboinflammation. International Journal of Molecular Sciences, 23(7), 3868. https://doi.org/10.3390/ijms23073868
  5. Stasi, R. (2012). How to approach thrombocytopenia. Hematology. American Society of Hematology. Education Program, 2012, 191-197. https://doi.org/10.1182/asheducation-2012.1.191

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey